Genos

Exhibitor

Unlock the Power of Glycomics with Genos

Genos Ltd. is a global leader in glycomics, delivering high-throughput, precision analysis of glycans - critical regulators of protein function and important contributors to human health and disease. Founded in Croatia and trusted worldwide, Genos transforms complex glycan data into actionable insights for biotech, pharmaceutical, research, and clinical applications.

Why Genos? Because Glycans Tell a Storey Others Can’t.

At the forefront of our expertise is immunoglobulin G (IgG) glycosylation - a rich source of biologically and clinically relevant biomarkers.

Changes in IgG glycan profiles can provide valuable insight into biological age, immune status, inflammation, and disease progression, adding a new dimension beyond conventional biomarkers.

Genos also integrates glycomics with epigenetics, enabling a more comprehensive understanding of gene regulation, biological processes, and disease mechanisms.

With Genos, You Gain Access To:

• High-throughput glycan analysis for large-scale studies and research cohorts
• In-depth glycan analysis of monoclonal antibodies supporting pharmaceutical development
• Robust and reproducible analytical workflows using LC, MS, and advanced data analysis and bioinformatics
• Integrated glycomics and epigenetics for deeper insight into biological mechanisms
• Custom CRISPR/dCas9 molecular tools for targeted epigenome editing through the Genos Plasmid Builder
• Glycan-based biomarker discovery and validation to support drug development and clinical research

 

From Data to Impact

We go beyond data generation.

Genos technologies and expertise support:

• Biomarker discovery & validation
• Population-scale glycosylation and epigenetic studies
• Precision medicine and multi-omics research
• Targeted epigenetic manipulation
• Development of diagnostic and prognostic tools

Introducing the Glycan Clock

Genos pioneered the Glycan Clock, a biomarker of biological age based on IgG glycosylation.

This innovation provides new opportunities in preventive medicine, patient stratification, and personalised health monitoring.

To bring glycan analysis closer to routine research and clinical use, Genos has developed a dedicated IgG glycan isolation kit, designed to support standardised sample preparation for research and diagnostic workflows and currently undergoing development for IVDR Class A compliance. In addition to the dedicated IgG glycan isolation kit, Genos also offers the GlycanAge Profiler, an instrument specifically adapted for glycan analysis, providing a streamlined solution for standardised and efficient glycan profiling.

By acquiring the GlycanAge Profiler together with the dedicated IgG glycan isolation kit, customers can perform glycan analyses directly at their own facilities, enabling an integrated in-house workflow from sample preparation to glycan profiling.

Your Partner in Innovation

By combining biochemistry, analytical technologies, bioinformatics, and epigenetics, Genos bridges the gap between complex molecular profiling and practical healthcare applications.

Whether you are developing a therapeutic, discovering or validating biomarkers, studying disease mechanism, or exploring novel diagnostics, Genos can help turn molecular complexity into meaningful insight.

Genos - Turning Glycomics into Impact.

 

website